We are seeking investors and partners to join with us in raising capital toward the following industry solutions:
JUNO AI-Based Viral Surveillance Platform:
COVID-19 Edition : JunoCOVID-Dx - a Rapid SARS CoV-2 Solution
A rapid, mobile metabolomics-based solution for diagnosing Covid-19 at scale that accounts for genetic viral mutations, enables personalized treatment and prevention, and tracks / predicts outbreaks via AI-enhanced automated data tracing. JUNO Metabolomics is partnering with U.S. military healthcare organizations in order to bring mass-testing capability to the armed forces and general public.
*Request more information for investors: email@example.com